GENERAL ATLANTIC, L.P.
New York, NY · CIK 1017645 · 13F filing filed 2020-02-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityGENERAL ATLANTIC, L.P. (US)
- Others nearbyNew York, NY
$3.7bn
reported value
8positions
100.0%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| XP INC XP | $2.4bn63.15% | — |
| 58 COM INC WUBA | $462.8m12.43% | — |
| SCIENCE APPLICATIONS INTL CO SAIC | $350.9m9.42% | — |
| ARCO PLATFORM LTD COM CL A | $243.2m6.53% | — |
| UBER TECHNOLOGIES INC UBER | $214.2m5.75% | — |
| CHINA INDEX HLDGS LTD SPNSRD ADS A | $36.8m0.99% | — |
| CROWDSTRIKE HLDGS INC CRWD | $32.4m0.87% | — |
| FANG HLDGS LTD SFUN | $31.8m0.85% | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| DLOCAL LTD DLO · 13D · filed 2026-08-19 | 21.4%≈ $478.4m |
| ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 | 18.1%≈ $351.9m |
| LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 | 15.0%≈ $608.1m |
| SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 | 11.5%≈ $132.5m |
| AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 | 8.4% |
| PHARVARIS N V PHVS · 13G · filed 2026-08-14 | 7.6%≈ $185.3m |
| CHIME FINL INC CHYM · 13G · filed 2025-11-10 | 5.6%≈ $393.4m |
| XP INC XP · 13D · filed 2025-12-04 | 5.4%≈ $370.1m |